Thrive Bioscience, Inc.

Thrive Bioscience, founded in 2014, is revolutionizing the field of biotechnology with its innovative imaging and automation technology. The company's mission, as articulated in its slogan, is to empower biologists by providing unparalleled insights into cell culture through cutting-edge instruments and software. Thrive Bioscience's suite of products integrates microscopy, robotics, and fluidics to capture images and data, enabling biologists to achieve consistent and reproducible outcomes. Its system not only enhances imaging and analytics but also provides analysis, reports, guidance, documentation, and a comprehensive database on cells and cell culture processes. This disruptive approach has attracted a considerable $13.50M investment in the form of a Convertible Note, received on 30 September 2020, underscoring the confidence of the investors in the promising future of Thrive Bioscience. With its focus on analytics and biotechnology, the company is poised to make a significant impact on the biotech industry.